Model-Based Meta-Analysis (MBMA) Archives

Publication

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…

Certara2025 年 11 月 5 日

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

Certara2025 年 10 月 31 日

Guide

MBMA vs. Meta-Analysis: Quick Comparison Guide

Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…

Certara2025 年 10 月 8 日

Blog

基于模型的荟萃分析（MBMA）在 GSK 的应用：对战略和临床试验的实际影响

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

Certara2025 年 7 月 31 日

Blog

5 大临床开发挑战 — 基于模型的荟萃分析（MBMA）助力应对

2025 年 6 月 30 日 Drug development is increasingly defined by its complexity. Teams must navigate rising…

Certara2025 年 6 月 30 日

On-Demand Webinar

从数据到决策：基于模型的荟萃分析（MBMA）与 GSK 和 Certara 真实世界影响

Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…

Certara2025 年 6 月 18 日

Publication

基于转化模型的荟萃分析，预测与血清素再摄取转运体抑制相关的震颤发生率

The serotonin reuptake transporter (SERT) is responsible for the removal and recycling of the neurotransmitter…

Certara2025 年 4 月 30 日

On-Demand Webinar

相对治疗效果和绝对结局的基于模型的荟萃分析：聚焦概念与应用

Vice President, MBMA Capability Lead, Certara Drug Development Solutions Matt advances the integration of published…

Certara2025 年 4 月 10 日

On-Demand Webinar

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

Vice President, Quantitative Science Services, Certara Matt advances the integration of published clinical outcomes data…

Certara2025 年 4 月 3 日

Publication

The Unrealized Potential of Advanced Modeling Methods to Inform Early Strategic Planning for Payer Reimbursement

This article explores the overlooked yet critical role of early strategic planning for payer reimbursement…

Certara2025 年 2 月 25 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

基于模型的荟萃分析（MBMA）

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

MBMA vs. Meta-Analysis: Quick Comparison Guide

基于模型的荟萃分析（MBMA）在 GSK 的应用：对战略和临床试验的实际影响

5 大临床开发挑战 — 基于模型的荟萃分析（MBMA）助力应对

从数据到决策：基于模型的荟萃分析（MBMA）与 GSK 和 Certara 真实世界影响

基于转化模型的荟萃分析，预测与血清素再摄取转运体抑制相关的震颤发生率

相对治疗效果和绝对结局的基于模型的荟萃分析：聚焦概念与应用

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

The Unrealized Potential of Advanced Modeling Methods to Inform Early Strategic Planning for Payer Reimbursement

订阅时事通讯

快捷链接

解决方案

联系我们